Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Neely

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2023
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I TrialEtan Orgel, Kristin R Knight, Yueh-Yun Chi, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2024
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trialHeidi Segers, Jaime G Deville, William J Muller, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 5, 2023
Correction to: Training the next generation of pharmacometric modelers: a multisector perspectivePeter L Bonate, Jeffrey S Barrett, Sihem Ait-Oudhia, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 13, 2023
Training the next generation of pharmacometric modelers: a multisector perspectivePeter L Bonate, Jeffrey S Barrett, Sihem Ait-Oudhia, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2021
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsAntonio C Arrieta, Michael Neely, J Christopher Day, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2023
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I TrialEtan Orgel, Kristin R Knight, Yueh-Yun Chi, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2024
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trialHeidi Segers, Jaime G Deville, William J Muller, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 5, 2023
Correction to: Training the next generation of pharmacometric modelers: a multisector perspectivePeter L Bonate, Jeffrey S Barrett, Sihem Ait-Oudhia, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 13, 2023
Training the next generation of pharmacometric modelers: a multisector perspectivePeter L Bonate, Jeffrey S Barrett, Sihem Ait-Oudhia, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2021
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsAntonio C Arrieta, Michael Neely, J Christopher Day, et al.
Pageof 10